Entropy Technologies LP increased its position in shares of Relx Plc (NYSE:RELX – Free Report) by 957.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 73,051 shares of the technology company’s stock after purchasing an additional 66,144 shares during the quarter. Entropy Technologies LP’s holdings in Relx were worth $2,953,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capital International Investors boosted its holdings in Relx by 66.7% during the fourth quarter. Capital International Investors now owns 10,662,595 shares of the technology company’s stock worth $433,887,000 after purchasing an additional 4,264,474 shares during the last quarter. Morgan Stanley boosted its stake in Relx by 7.0% in the fourth quarter. Morgan Stanley now owns 6,279,696 shares of the technology company’s stock valued at $253,825,000 after acquiring an additional 408,833 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Relx by 1.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,502,488 shares of the technology company’s stock valued at $141,583,000 after acquiring an additional 56,363 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in Relx by 1.4% in the third quarter. Ameriprise Financial Inc. now owns 3,390,649 shares of the technology company’s stock valued at $164,120,000 after acquiring an additional 46,515 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in Relx by 3.5% in the third quarter. Northern Trust Corp now owns 2,430,755 shares of the technology company’s stock valued at $116,093,000 after acquiring an additional 81,195 shares during the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Trading Down 0.1%
NYSE RELX opened at $33.71 on Monday. The company’s 50 day moving average is $34.28 and its 200-day moving average is $35.90. Relx Plc has a 12-month low of $27.57 and a 12-month high of $54.37. The company has a debt-to-equity ratio of 2.38, a current ratio of 0.49 and a quick ratio of 0.44.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on RELX
Relx Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
See Also
- Five stocks we like better than Relx
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
